Global Imipenem/Cilastatin Market Insights, Size and Growth Forecast To 2023

Published: Oct 2018	Report ID: PHAR1810	Pages: 1 - 100	Formats^*:
Category : Pharmaceutical

Report description

"Imipenem/Cilastatin" is a combination drug consists of two individual drugs: Imipenem and Cilastatin Sodium in the ratio of 1:1 by weight. â€œPrimaxinâ€ the brand of Originator Merck & Co. contains Imipenem & Cilastatin, a new beta-lactam agent of the carbapenem class (1-Beta-methyl carbapenem). Primaxin is an antibiotic useful for the treatment of a number of bacterial infections. Imipenem/Cilastatin current market size is 5446.69 Million USD, with a CAGR of 17% for the session 2014-2017 & it is forecasted to grow with a CAGR of 23% during the session of 2018-2023. The multiple indications among all other carbapenemâ€™s provide contribution in the market growth. Imipenem is a white or pale yellow powder & broad-spectrum beta-lactam antibiotic & Cilastatin sodium is light yellow hygroscopic, amorphous powder. "Imipenem/Cilastatin" is off white to yellowish white hygroscopic powder. For injection formulation it is available in two forms i.e. powder & solution. It is given by injection into a vein or muscle. Primaxin (Imipenem and Cilastatin for Injectable Suspension) is a formulation of Imipenem (a thienamycin antibiotic) and Cilastatin sodium (the inhibitor of the renal dipeptidase, dehydropeptidase-I). Primaxin is a potent broad spectrum antibacterial agent for intramuscular administration.

The activity of â€œImipenem/Cilastatinâ€ against an unusually broad spectrum of pathogens makes it particularly useful in the treatment of polymicrobic mixed aerobic/anaerobic infections as well as initial therapy prior to the identification of the causative organisms. Imipenem/Cilastatin is indicated for the treatment of the following infections due to susceptible organisms:

Intra-Abdominal Infections
Lower Respiratory Tract Infections
Gynaecological Infections
Septicaemia
Genitourinary Tract Infections
Bone & Joint Infections
Skin & Soft Tissue Infections
Endocarditis

This report represents the global and regional analysis of "Imipenem/Cilastatin" in terms of Dosage, Strength, API, application wise segmentation, market size & market growth (in terms of value & volume) trends including forecasting upto 5 years. All the region wise segmentation of buyer supplier is described properly. The report focuses on the top continent wise (North America, Europe, Asia, South America, Africa & Oceania) manufacturer & consumer analysis & market share.

Report highlights

Provide manufacturing capacity, consumption, current & past status & also the forecasting upto 2023.
Provide complete overview including type, application & forecast region.
Provide complete analysis of API & formulation including brand names, strength & market overview.
Provide focused analysis of key manufacturer with their production volume, market share & also help to identify market competition landscape with SWOT analysis.
Historical, current and projected market size in terms of volume and value.
Analyze the global & regional potential market, advantages, risk & opportunity.
Identify significant trends and factors driving or inhibiting the market growth.
In-depth coverage of complete market in terms of supplier, buyer, price, trend, growth & forecasting.

The report covers Imipenem/Cilastatin forms

Imipenem/Cilastatin As Injection
Imipenem/Cilastatin As Freeze Dried Powder

The report covers Imipenem/Cilastatin end users

Imipenem/Cilastatin In Hospital
Imipenem/Cilastatin In Clinic
Imipenem/Cilastatin In Other

The report covers exhaustive analysis on

Market Segments
Market Dynamics
Brands In Market
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Forecasting
Technology

The report includes Regional analysis on

North America (U.S., Canada)
Latin America (Brazil, Mexico, Rest of Latin America)
Europe (Germany, Italy, France, U.K, Spain & Rest of Europe)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Middle East and Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)

Top Players in Imipenem/Cilastatin industry

Merck Sharp Dohme Corp.
Sun Pharmaceutical Industries Ltd
******************************
Vitalis SACI
******************************

Key Questions answered by report

What was the market size trend of 2014-2017?
What will be the market size trend of next 4-5 years?
What are the most common brands in terms of volume?
How much brands available for Imipenem/Cilastatin?
Who are the key players of Imipenem/Cilastatin API?
What are the major application industries & emerging industries?
Who are the key vendors present in the market?
How the future opportunities & market drivers will affect the market dynamics & ongoing trends?
Which one segment from global coverage will be lucrative & will grow?
What are the main market opportunities and threats faced by the vendors?
What are the strategies are following by the existing market players?

CHAPTER 1 RESEARCH METHODOLOGY

CHAPTER 2 REPORT DESCRIPTION

CHAPTER 3 IMIPENEM/CILASTATIN EXECUTIVE SUMMARY

CHAPTER 4 IMIPENEM/CILASTATIN BASIC HIGHLIGHTS

4.1. Product Overview
4.2. CAS No & Molecular Weight
4.3. Innovator & Developer Details
4.4. Priority & Patent Expiry
4.5. Molecular Formula
4.6. Market Status

CHAPTER 5 GLOBAL IMIPENEM/CILASTATIN PHYSICAL FORMS, GRADES & APPLICATION INDUSTRY

5.1. Imipenem/Cilastatin Forms (Crystalline or Amorphous)
5.2. Imipenem/Cilastatin Grades Description & Variants
5.3. Imipenem/Cilastatin Route of Administration
5.4. Imipenem/Cilastatin Synonym
5.5. Imipenem/Cilastatin Forms

5.5.1. Freeze Dried Powder
5.5.2. Injectable

5.6. Imipenem/Cilastatin End Users

5.6.1. Hospital
5.6.2. Clinic
5.6.3. Other

CHAPTER 6 IMIPENEM/CILASTATIN MANUFACTURING PROCESS WITH UPSTREAM & DOWNSTREAM

6.1. Imipenem/Cilastatin Manufacturing Process Routes & Flow Chart
6.2. Imipenem/Cilastatin Upstream & Downstream Products

CHAPTER 7 IMIPENEM/CILASTATIN BRAND LIST & MECHANISM OF ACTION

7.1. Imipenem/Cilastatin All Global Brands
7.2. Imipenem/Cilastatin Dosage & Their Strengths
7.3. Imipenem/Cilastatin Mechanism of Action

CHAPTER 8 IMIPENEM/CILASTATIN (API) REGION WISE MARKET OVERVIEW

8.1. Imipenem/Cilastatin Market Overview In Asia (China, India & Taiwan)

CHAPTER 9 IMIPENEM/CILASTATIN (FORMULATION) REGION WISE MARKET OVERVIEW

9.1. Imipenem/Cilastatin Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
9.2. Imipenem/Cilastatin Market Overview In Europe (Switzerland, Austria, Greece, United Kingdom & Rest of Europe Available)
9.3. Imipenem/Cilastatin Market Overview In North America (United State)
9.4. Imipenem/Cilastatin Market Overview In South America (Brazil, Argentina, Bolivia, Paraguay & Rest of South America Available)
9.5. Imipenem/Cilastatin Market Overview In Oceania (New Zealand)

CHAPTER 10 IMIPENEM/CILASTATIN (API & FORMULATION) CONTINENT & COUNTRY WISE MANUFACTURERS, MANUFACTURING VOLUME & CONTACT OVERVIEW

10.1. Imipenem/Cilastatin Continent Wise Manufacturers
10.2. Imipenem/Cilastatin Continent Wise Manufacturing Volume
10.3. Imipenem/Cilastatin Country Wise Manufacturers
10.4. Imipenem/Cilastatin Country Wise Manufacturing Volume
10.5. Imipenem/Cilastatin Manufacturers Contact Overview

CHAPTER 11 IMIPENEM/CILASTATIN GLOBAL PRICE TREND ANALYSIS OF LAST 3 YEARS

11.1. Imipenem/Cilastatin Global Price Trend Analysis
11.2. Imipenem/Cilastatin Country Wise Price Trend Analysis

CHAPTER 12 IMIPENEM/CILASTATIN INTERNATIONAL MARKET OVERVIEW

12.1. Global Demand/ Supply & Global Prices
12.2. Major Destinations Involved In Trade
12.3. Major Manufacturers (Capacities & Prices)

CHAPTER 13 IMIPENEM/CILASTATIN (FORMULATION) GLOBAL MARKET SIZE & MARKET GROWTH FORECASTING (2018-2023) ANALYSIS

13.1. Imipenem/Cilastatin Global Market Size (Past & Future Forecasting)
13.2. Imipenem/Cilastatin Global Market Growth (Past & Future Forecasting)
13.3. Imipenem/Cilastatin Continent Wise Market Size (Past & Future Forecasting)
13.4. Imipenem/Cilastatin Continent Wise Market Growth (Past & Future Forecasting)

CHAPTER 14 IMIPENEM/CILASTATIN (FORMULATION) CUSTOMER WISE CONSUMPTION, QUANTITY & CONTACT OVERVIEW

14.1. Imipenem/Cilastatin Global Consumers
14.2. Imipenem/Cilastatin Global Consumers As Per Consumption Quantity
14.3. Imipenem/Cilastatin Continent Wise Consumer
14.4. Imipenem/Cilastatin Continent Wise Consumer As Per Consumption Quantity
14.5. Imipenem/Cilastatin Country Wise Consumer
14.6. Imipenem/Cilastatin Country Wise Consumer As Per Consumption Quantity
14.7. Imipenem/Cilastatin Consumers Contact Overview

CHAPTER 15 IMIPENEM/CILASTATIN (API) CONTINENT WISE EXPORT/ IMPORT ANALYSIS

15.1. Imipenem/Cilastatin (API) Continent Wise Import Analysis
15.2. Imipenem/Cilastatin (API) Continent Wise Export Analysis
15.3. Imipenem/Cilastatin (API) Country Wise Import Analysis
15.4. Imipenem/Cilastatin (API) Country Wise Export Analysis

CHAPTER 16 IMIPENEM/CILASTATIN (Formulation) CONTINENT WISE EXPORT/ IMPORT ANALYSIS

16.1. Imipenem/Cilastatin (Formulation) Continent Wise Import Analysis
16.2. Imipenem/Cilastatin (Formulation) Continent Wise Export Analysis
16.3. Imipenem/Cilastatin (Formulation) Country Wise Import Analysis
16.4. Imipenem/Cilastatin (Formulation) Country Wise Export Analysis

CHAPTER 17 IMIPENEM/CILASTATIN WORLDWIDE SWOT ANALYSIS

17.1. Imipenem/Cilastatin Strength Analysis
17.2. Imipenem/Cilastatin Weakness Analysis
17.3. Imipenem/Cilastatin Opportunity Analysis
17.4. Imipenem/Cilastatin Threat Analysis

CHAPTER 18 IMIPENEM/CILASTATIN REPORT BASED BUSINESS RECOMMENDATION

List of Tables

Table 1 : Route of Administration
Table 2 : Available Composition of Imipenem/Cilastatin
Table 3 : Dosage Representation Depending Upon Infection Severity
Table 4 : Raw Material Required for 1000 Mg Injection
Table 5 : List of Manufacturing Equipment Required
Table 6 : List of Global Brand With Strength & Dosage Type
Table 7 : Country Wise API Asian Market Overview
Table 8 : Country Wise Formulation Asian Market Overview
Table 9 : Country Wise Formulation European Market Overview
Table 10: Country Wise Formulation South American Market Overview
Table 11: Country Wise Formulation North American Market Overview
Table 12: Country Wise Formulation Oceania Market Overview
Table 13: Global API Manufacturer Overview
Table 14: Country Wise Global API Manufacturer Market Overview
Table 15: API Manufacturer Deliverable Format
Table 16: Formulation Global Manufacturer Market Overview
Table 17: Formulation Manufacturer Deliverable Format
Table 18: API Continent & Country Wise 2015 Price Range Analysis
Table 19: API Continent & Country Wise 2016 Price Range Analysis
Table 20: API Continent & Country Wise 2017 Price Range Analysis
Table 21: API Continent & Country Wise 2018 (Jan to July) Price Range Analysis
Table 22: Formulation Continent & Country Wise 2015 Price Range Analysis
Table 23: Formulation Continent & Country Wise 2016 Price Range Analysis
Table 24: Formulation Continent & Country Wise 2017 Price Range Analysis
Table 25: Formulation Continent & Country Wise 2018 (Jan to July) Price Range Analysis
Table 26: List of Top 10 Manufacturer With Brand Name & Approximate Price
Table 27: Market Size in Terms of Volume (MTS) Analysis (2014-18)
Table 28: Market Size in Terms of Value (M USD) Analysis (2014-18)
Table 29: Market Size in Terms of Volume (MTS) Analysis (2018-23)
Table 30: Market Size in Terms of Value (M USD) Analysis (2018-23)
Table 31: Global Imipenem/Cilastatin Consumer Analysis
Table 32: Global Imipenem/Cilastatin Consumer Deliverable Format
Table 33: Global Imipenem/Cilastatin API Export Analysis (2017-18)
Table 34: Global Imipenem/Cilastatin API Import Analysis (2017-18)
Table 35: Global Imipenem/Cilastatin API Export-Import Analysis (2015-18)
Table 36: Global Imipenem/Cilastatin Continent Wise API Import Analysis (2015-18)
Table 37: Global Imipenem/Cilastatin Continent Wise API Export Analysis (2015-18)
Table 38: Global Imipenem/Cilastatin Country Wise API Import Analysis (2015-18)
Table 39: Global Imipenem/Cilastatin Country Wise API Export Analysis (2015-18)
Table 40: Global Imipenem/Cilastatin Importer Wise Import Analysis (2015-18)
Table 41: Global Imipenem/Cilastatin Exporter Wise Export Analysis (2015-18)
Table 42: Global Imipenem/Cilastatin Export Analysis (2017-18)
Table 43: Global Imipenem/Cilastatin Import Analysis (2017-18)
Table 44: Global Imipenem/Cilastatin Export-Import Analysis (2015-18)
Table 45: Global Imipenem/Cilastatin Import Analysis (2015-18)
Table 46: Global Imipenem/Cilastatin Export Analysis (2015-18)
Table 47: Global Imipenem/Cilastatin Country Wise Import Analysis (2015-18)
Table 48: Global Imipenem/Cilastatin Country Wise Export Analysis (2015-18)
Table 49: Global Imipenem/Cilastatin Importer Wise Import Analysis (2015-18)
Table 50: Global Imipenem/Cilastatin Exporter Wise Export Analysis (2015-18)

List of figure

Figure 1 : Imipenem/Cilastatin Structure
Figure 2 : Imipenem/Cilastatin Dosage Type
Figure 3 : Imipenem/Cilastatin Upstream & Downstream Application Flow Chart
Figure 4 : Imipenem/Cilastatin Mechanism of Action
Figure 5 : Asian API Country Wise Market Overview
Figure 6 : Asian Formulation Country Wise Market Overview
Figure 7 : European Formulation Country Wise Market Overview
Figure 8 : South American Formulation Country Wise Market Overview
Figure 9 : Global Country Wise API Manufacturer
Figure 10: Global Country Wise API No. of Manufacturer Production Volume
Figure 11: Global Country Wise Top API Manufacturer With Production Analysis
Figure 12: Country Wise Market Share Analysis
Figure 13: Continent Wise Formulation No. of Manufacturer
Figure 14: Continent Wise Formulation Manufacturer Production Volume
Figure 15: Global Continent Wise Top Formulation Manufacturer With Production Analysis
Figure 16: Global Continent Wise Market Share Analysis
Figure 17: Global Demand Supply Overview Analysis
Figure 18: Global Continent Wise No. of Consumer
Figure 19: Global Continent Wise No. Consumption Volume
Figure 20: Global Continent Wise No. Top Consumer Analysis
Figure 21: Global Country Wise market Share Overview
Figure 22: Global Continent Wise API Export Overview
Figure 23: Global Continent Wise API Import Overview
Figure 24: Global Continent Wise API Export-Import (2015-2018) Overview
Figure 25: Global Continent Wise Formulation Export Overview
Figure 26: Global Continent Wise Formulation Import Overview
Figure 27: Global Continent Wise Formulation Export Import (2015-2018) Overview

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1